Skip to main content
. 2012 Jan 10;12:3. doi: 10.1186/1471-2288-12-3

Figure 2.

Figure 2

Risk-benefit planes showing the joint incremental risk and benefit of anticoagulants used for venous thromboembolism prophylaxis in orthopedic surgery. The figure shows separate analyses for patients receiving ximelagatran (A), low molecular weight heparin (B), Unfractionated heparin (C), warfarin (D) and fondaparinux (E). The dashed line corresponds to the reference value for the risk benefit acceptability threshold.